神経治療学
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
特集 脳表ヘモジデリン沈着症
脳表ヘモジデリン症とアミロイド
高橋 佑介矢﨑 正英関島 良樹
著者情報
ジャーナル フリー

2021 年 38 巻 2 号 p. 102-106

詳細
抄録

Cerebral amyloid angiopathy (CAA), which results from amyloid deposition in the small and medium–sized blood vessels of the leptomeninges and central nervous system, is one of the cardinal causes of superficial siderosis (SS). Several amyloid precursor proteins are known to cause CAA. Aβ type CAA is the most frequently found in elderly people or patients with Alzheimer's disease (AD). Cystatin C, prion protein, ABri/ADan, transthyretin (TTR), and gelsolin, are all associated with hereditary CAA. Hereditary ATTR (ATTRv) amyloidosis is an autosomal dominant disease caused by mutations in TTR gene. In several specific TTR mutations including L12P, D18G, A25T, V30G, A36P, T49P, G53E, G53A, G53R, F64S, T69H, and Y114C, leptomeningeal vessels are severely involved by amyloid deposits. On the other hand, in TTR V30M, which is the most common variant type in Japanese hereditary ATTR amyloidosis, CAA was not so noticeable except for homozygous V30M patients. However, with improvement of the prognosis by liver transplantation or disease modifying drugs, CAA has recently become a major problem even in heterozygous V30M patients. These patients developed transient ischemic attack (TIA)–like episodes, stroke, and intracranial hemorrhages, causing SS.

著者関連情報
© 2021 日本神経治療学会
前の記事 次の記事
feedback
Top